L-Citrulline and Blood Pressure: Evidence, Usage, and Safety (vs. L-Arginine)
Reading time: 9–12 minutes • Educational only.
What the research suggests
- L-citrulline meta-analysis (8 trials): pooled changes SBP −4.10 mmHg (95% CI −7.94 to −0.26); DBP −2.08 mmHg overall, with significant DBP reduction at ≥6 g/day.
- L-arginine (22 RCTs): average SBP −6.4 mmHg and DBP −2.6 mmHg in dose-response analysis.
- Why citrulline is often preferred: it raises plasma arginine more reliably than oral arginine (better bioavailability), supporting NO production.
Takeaway: effects are small on average and should be viewed as adjunctive.
How people typically use it (study-aligned)
- Dose & duration: 3–6 g/day L-citrulline for 2–8+ weeks. Split doses if GI upset.
- When to take: with or without food; keep timing consistent.
- How to track: capture a 7-day average before and after 2–4 weeks: How to Measure & Track.
Safety & interactions
- Additive BP-lowering with antihypertensives is possible—coordinate with your clinician.
- Caution with nitrates or PDE-5 inhibitors: NO-pathway supplements (arginine/citrulline) may potentiate hypotension; PDE-5 inhibitors and nitrates should not be combined without medical supervision.
- Typical side effects are uncommon (GI upset, headache); discontinue if adverse effects occur.
Lifestyle tie-ins
Educational Disclaimer: This article is for educational purposes only and is not medical advice.
References
- Barkhidarian B, et al. L-citrulline and BP (meta-analysis). PMC.
- Shiraseb F, et al. L-arginine and BP (dose-response meta-analysis). ScienceDirect. See summary: Mayo Clinic.
- Rashid J, et al. Citrulline as an arginine supplement (PK/PD). PMC.
- Drugs.com Professional — Arginine/Citrulline & vasodilators. Drugs.com.
- ACC / StatPearls — PDE-5 inhibitors + nitrates. ACC ; StatPearls.